TOKYO, JAPAN — eCyte is proud to announce that it has been awarded the prestigious "Innovation Award 2026" at the 2nd International Conference on Targeting Microbiota, jointly hosted by the RIKEN Center for Integrative Medical Sciences and the International Society of Microbiota (ISM) in Tokyo, Japan.
Recognizing Global Impact & Award Prestige
Co-organized by RIKEN—Japan’s premier natural sciences research institute—and the International Society of Microbiota (ISM), this global conference brings together world-class researchers, clinician-scientists, and biotech leaders in microbiome science.
Winning the Innovation Award 2026 at this high-level forum highlights eCyte's vital role in advancing global single-cell technology:
International Scientific Endorsement: It represents unanimous recognition from global experts for eCyte’s label-free, high-throughput, and function-driven single-cell sorting capabilities powered by FlowRACS.
Overcoming Long-Standing Bottlenecks: By enabling rapid, non-destructive metabolic profiling and target cell recovery without prior cultivation, eCyte’s RAMS technology solves the critical "uncultivable microbial dark matter" challenge in microbiome sequencing.
Accelerating Translational Research: FlowRACS and RAMS empower researchers to bridge complex microbial composition with direct function, paving the way for next-generation live biotherapeutic products (LBPs), precision medicine, and industrial biotechnology.
Leadership Voice
"We are deeply honored to receive the Innovation Award at the Riken-ISM Joint Conference," said the representative of eCyte. "This recognition validates our continuous innovation with FlowRACS and RAMS. We remain dedicated to equipping global scientists with pioneering single-cell Raman tools to unlock the vast, uncharted potential of the microbiome."
This global honor was presented in recognition of the technological breakthroughs behind eCyte’s signature innovations: FlowRACS (Flow Cytometric Raman-Activated Cell Sorter) and RAMS (Raman-Activated Microfluidic Sorter). Standout performers among numerous international scientific and industrial competitors, these platforms represent a major leap forward in functional single-cell screening and sorting for microbiome research.